Notably, studies reporting elevated C1q involved patients with TDP-43 inclusions [17,47]—a hallmark of FTD linked to C9ORF72 and GRN mutation—and one study found higher C1q in symptomatic versus presymptomatic C9ORF72 mutation carriers [8]. The gene discussed is TARDBP; the disease is frontotemporal dementia.